| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |